Entera Bio Ltd.
ENTX
$2.06
-$0.16-7.21%
NASDAQ
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 40.51% | -20.28% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 22.04% | 2.42% | |||
| Operating Income | -22.04% | -4.10% | |||
| Income Before Tax | -20.48% | -3.47% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -20.48% | -3.47% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -20.48% | -3.47% | |||
| EBIT | -22.04% | -4.10% | |||
| EBITDA | -22.06% | -4.15% | |||
| EPS Basic | -19.93% | 4.22% | |||
| Normalized Basic EPS | -20.06% | 4.32% | |||
| EPS Diluted | -19.93% | 4.22% | |||
| Normalized Diluted EPS | -20.06% | 4.32% | |||
| Average Basic Shares Outstanding | 0.54% | 7.97% | |||
| Average Diluted Shares Outstanding | 0.54% | 7.97% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||